CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy Chief Financial Officer bought 27,000 shares at $1.27 ($34,177)
- 8-K Event Delisting notice
- 4 Open-market buy Chief Executive Officer bought 2,750 shares at $1.80 ($4,945)
- 8-K Event Bylaws or fiscal year change
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Derivatives Options or other derivatives
- 4 Planned sale 10% owner sold 94,298 shares at an average $1.41 ($133,114)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Option exercise Chief Executive Officer acquired 1,250 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 521 shares (option exercise)
Page 11 of 20 · 390 filings